Physician profile
James Johnson
NPI 1609923416
$1,658.12
in general payments reported to CMS, 2019-2025
20 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $39.23 · 2021: $113 · 2022: $304 · 2023: $447 · 2024: $195 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $243.49 | 2019-2025 | Dovato, Cabenuva |
| Merck Sharp & Dohme LLC | $227.13 | 2021-2025 | Zerbaxa, Dificid, Recarbrio |
| Paratek Pharmaceuticals, INC. | $174.45 | 2019-2025 | Nuzyra |
| Astellas Pharma US INC | $156.57 | 2019-2025 | Cresemba |
| Modernatx, INC. | $152.91 | 2023-2024 | Moderna Covid-19 Vaccine |
| Insmed, INC. | $125.67 | 2019-2025 | Arikayce, Brinsupri |
| Abbvie INC. | $120.72 | 2021-2025 | |
| Melinta Therapeutics, LLC | $98.64 | 2022-2024 | Rezzayo |
| Gilead Sciences, INC. | $69.66 | 2019-2025 | |
| Theratechnologies INC. | $57.91 | 2022-2023 | Egrifta, Trogarzo |
| La Jolla Pharmaceutical Company | $38.67 | 2022-2025 | Xacduro |
| Tetraphase Pharmaceuticals, INC. | $37.09 | 2019 | |
| Ferring Pharmaceuticals INC. | $34.05 | 2023-2025 | Rebyota |
| Janssen Scientific Affairs, LLC | $19.67 | 2020 | |
| Nabriva Therapeutics, Plc | $19.56 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $19.41 | 2025 | Vowst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.51 | 2019 | |
| Integra Lifesciences Corporation | $17.04 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $15.83 | 2022 | |
| Janssen Biotech, INC. | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.